Clicky

Seres Therapeutics, Inc.(MCRB) News

Date Title
May 6 Seres Therapeutics to Announce First Quarter 2024 Financial Results and Business Update on May 8, 2024
Apr 9 Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
Mar 28 Increases to Seres Therapeutics, Inc.'s (NASDAQ:MCRB) CEO Compensation Might Cool off for now
Mar 19 Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 13 11 Oversold NASDAQ Stocks To Buy Right Now
Mar 13 11 Oversold Healthcare Stocks To Buy Right Now
Mar 7 Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2023 Earnings Call Transcript
Mar 6 Q4 2023 Seres Therapeutics Inc Earnings Call
Mar 5 Seres Therapeutics Inc (MCRB) Reports Encouraging Sales Growth and Strategic Cost Savings in 2023
Mar 5 Seres Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
Jan 9 Seres Therapeutics Announces VOWST™ Commercial Launch Update and US FDA Fast Track Designation for SER-155
Jan 4 Seres Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Dec 8 Seres Therapeutics Announces Presentation of Preliminary PK/PD and Safety Data for Investigational Microbiome Therapeutic SER-155 at ASH 2023
Dec 2 Seres Therapeutics, Inc. (NASDAQ:MCRB) is a favorite amongst institutional investors who own 62%
Nov 28 Seres Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023; Webcast at 3:30 p.m. ET
Nov 5 Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2023 Earnings Call Transcript
Nov 2 Seres Therapeutics Reports Third Quarter 2023 Financial Results Including VOWST™ Net Sales of $7.6 Million
Aug 9 Investors Don't See Light At End Of Seres Therapeutics, Inc.'s (NASDAQ:MCRB) Tunnel
Aug 8 Seres Therapeutics (MCRB) Misses Q2 Earnings Estimates
Aug 8 Seres Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates